Sven Klussmann
Chief Tech/Sci/R&D Officer at NOXXON Pharma AG
Sven Klussmann active positions
| Companies | Position | Start | End |
|---|---|---|---|
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Chief Tech/Sci/R&D Officer | 1996-12-31 | - |
| President | 1996-12-31 | 2009-11-15 |
Career history of Sven Klussmann
Former positions of Sven Klussmann
| Companies | Position | Start | End |
|---|---|---|---|
| TME PHARMA N.V. | Chief Tech/Sci/R&D Officer | 1996-12-31 | - |
| Founder | 1996-12-31 | - |
Training of Sven Klussmann
| Freie Universität Berlin | Undergraduate Degree |
Statistics
International
| Germany | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| President | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TME PHARMA N.V. | Health Technology |
| Private companies | 1 |
|---|---|
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
- Stock Market
- Insiders
- Sven Klussmann
- Experience
